Online citations, reference lists, and bibliographies.

Pleural Resection And Pleural Infusion Chemotherapy For Therapy Of Malignant Pleural Mesothelioma.

J. Zhang, Q. Zhang, W. Zhao, J. Duan, T. Huang
Published 2014 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
The aim of this study was to evaluate effective treatment methods of malignant pleural mesothelioma (MPM). Twenty-three patients with MPM were cured by pleural infusion chemotherapy after surgery. Median survival time and the 1-, 2-, and 3-year survival rates were analyzed on the basis of follow-up. Median survival time of all patients was 15 months (range: 3 to 89 months); the 1-, 2-, and 3-year survival rates were 69.6, 43.5, and 13.0%, respectively. The 1-year survival rates of patients in stages I, II, and III were 83.3, 62.5, and 33.3%, respectively, the 2-year survival rates were 50, 37.5, and 33.3%, respectively, and the 3-year survival rates were 34, 23, and 0%, respectively. Surgery-oriented comprehensive treatment was adopted for MPM, which could improve the prognosis and life quality of patients to some extent.
This paper references
Patterns of failure after trimodality therapy for malignant pleural mesothelioma.
E. Baldini (1997)
Surgical therapy for malignant pleural mesothelioma
Chen Wen-hu (2002)
Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
H. Pass (2006)
p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.
S. Hopkins-Donaldson (2006)
p53-induced apoptosis
ヴォーゲルスタイン,バート (1998)
Radiation therapy options for malignant pleural mesothelioma.
Elizabeth H. Baldini (2009)
Cancer: Principles and Practice of Oncology
G. Steele (1983)
Thorac. Cardiovasc. Surg
decortication. Semin (2005)
Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
H. Yang (2008)
The Treatment of Malignant Mesothelioma of the Pleura: Review of a 5‐Year Experience, With Special Reference to Radiotherapy
D. Ball (1990)
Phase III study of pemetrexed in combination
NJ Vogelzang (2003)
Current trends in radiologic management of malignant pleural mesothelioma.
Ritu R Gill (2009)
Malignant mesothelioma following radiation exposure.
K. H. Antman (1983)
CT appearances of pleural tumours.
H. Salahudeen (2009)
Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors.
A. Hanauske (2001)
Malignant pleural mesothelioma.
A. Tsao (2009)
multiple solid tumors
R Hassan (2008)
Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication.
Raja M Flores (2009)
Diagnosis, Staging, and Surgical Treatment of Malignant Pleural Mesothelioma
M. Kent (2008)
FDA drug approval summaries: pemetrexed (Alimta).
M. Hazarika (2004)
Treatment of Malignant Mesothelioma
M. D. Michael T. Jaklitsch (2001)
[Surgical therapy of malignant pleural mesothelioma].
Moritz Schirren (2016)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
JR Testa (2008)
p 53induced apoptosis occurs in the absence of p 14 ( ARF ) in malignant pleural mesothelioma
MT Jaklitsch (2006)
Malignant pleural mesothelioma: current concepts in treatment
A. Tsiouris (2007)
Gene therapy for mesothelioma and lung cancer.
A. Vachani (2010)
Medical thoracoscopy for diagnosis and treatment of pleural mesothelioma
Li Jing (2005)
Malignant pleural mesothelioma.
L. Ho (2001)
Mesothelin targeted cancer immunotherapy.
R. Hassan (2008)
Treatment of Malignant Mesothelioma
M. Jaklitsch (2001)
[Malignant mesothelioma].
J. Espinosa Arranz (1994)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar